中国首例Silara?-Valve经导管主动脉瓣置换术The first case of transcatheter aortic valve replacement with Silara?-Valve in China
陈阳,宋光远,牛冠男,王墨扬,周政,赵振燕,随永刚,张海彤,吴永健
摘要(Abstract)：
探讨中国首例Silara~?-Valve(原Direct Flow)瓣膜在经导管主动脉瓣置换术中的应用情况。回顾性分析2020年12月16日阜外医院首次开展的1例经导管Silara~?-Valve主动脉瓣置换术的手术过程与患者围术期情况。1例外科手术中危的症状性严重主动脉瓣狭窄患者在局部麻醉和镇静下成功接受了Silara~?-Valve瓣膜经导管主动脉瓣置换术,术后瓣膜位置、功能良好,无反流,该患者症状明显缓解。经导管Silara~?-Valve主动脉瓣置换术安全可行,后续前瞻性、多中心临床试验有望评估其疗效。
关键词(KeyWords)： Silara~?-Valve瓣膜;主动脉瓣狭窄;经导管主动脉瓣置换术
基金项目(Foundation):
作者(Author): 陈阳,宋光远,牛冠男,王墨扬,周政,赵振燕,随永刚,张海彤,吴永健
参考文献(References)：
- [1] Otto CM, Nishimura RA, Bonow RO,et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol, 2021,77(4):e25-e197.
- [2]中国医师协会心血管内科医师分会结构性心脏病专业委员会.经导管主动脉瓣置换术中国专家共识（2020更新版）.中国介入心脏病学杂志，2020, 28(6):301-309.
- [3]中华医学会心血管病学分会结构性心脏病学组，中国医师协会心血管内科医师分会结构性，心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识.中国循环杂志，2018, 33(12):1162-1169.
- [4] Low RI, Bolling SF, Yeo KK,et al. Direct fl ow medical percutaneous aortic valve:proof of concept. EuroIntervention, 2008, 4(2):256-261.
- [5] Schofer J, Schluter M, Treede H,et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgicalrisk patients with severe aortic stenosis:a fi rst-in-man feasibility and safety study. Circ Cardiovasc Interv, 2008, 1(2):126-133.
- [6] De Marco F, Latib A. Tools and Techniques-Clinical:the inner curve technique for implantation of the Direct Flow Medical?transcatheter aortic valve. EuroIntervention, 2014, 10(3):400-402.
- [7] Schofer J, Colombo A, Klugmann S,et al. Prospective multicenter evaluation of the direct fl ow medical transcatheter aortic valve. J Am Coll Cardiol, 2014, 63(8):763-768.
- [8] Lefèvre T, Colombo A, TchétchéD,et al. Prospective multicenter evaluation of the direct fl ow medical transcatheter aortic valve system.JACC Cardiovasc Interv, 2016, 9(1):68-75.
- [9] Gamal AS, Akleh S, Zaman A,et al. Outcomes of direct fl ow medical vs sapien 3 transcatheter aortic valve devices. J Cardiovasc Transl Res, 2020, 13(5):790-795.